Furthermore, AD alters other proteins in the corneal layer, including corneal adhesion, loricrin (LOR), and involucrin (IVL), resulting in compromised skin barrier function and type 2 immune response (56–59). The gene discussed is LORICRIN; the disease is Alzheimer disease.